Rallybio to Present at Upcoming Investor Conferences in September
- None.
- None.
-
2023 Wells Fargo Healthcare Conference in
Everett, MA on Thursday, September 7, 2023. Stephen Uden, M.D., Chief Executive Officer, and Martin Mackay, Ph.D., Executive Chairman, will participate in a fireside chat at 12:45 p.m. ET. -
H.C. Wainwright 25th Annual Global Investment Conference in
New York, NY on Tuesday, September 12, 2023. Dr. Uden will participate in a panel discussion, “A New Era for Complement Inhibitors,” at 10:00 a.m. ET. -
2023 Cantor Global Healthcare Conference in
New York, NY on Wednesday, September 27, 2023. Dr. Uden and Dr. Mackay will participate in a fireside chat at 4:10 p.m. ET.
Live webcasts of the Wells Fargo and Cantor fireside chats will be accessible through the Events and Presentations section of Rallybio’s website at www.rallybio.com. A replay of the webcasts will be available for 30 days following each presentation.
About Rallybio
Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. Rallybio has built a broad pipeline of promising product candidates aimed at addressing diseases with unmet medical need in areas of maternal fetal health, complement dysregulation, hematology, and metabolic disorders. The Company has two clinical stage programs: RLYB212, an anti-HPA-1a antibody for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and RLYB116, an inhibitor of complement component 5 (C5), with the potential to treat several diseases of complement dysregulation, as well as additional programs in preclinical development.
Rallybio is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20230824296440/en/
Investors
Ami Bavishi
Head of Investor Relations and Communications
475-47-RALLY (Ext. 282)
abavishi@rallybio.com
Hannah Deresiewicz
Stern Investor Relations, Inc.
212-362-1200
hannah.deresiewicz@sternir.com
Media
Jorge Gaeta
Mission North
(516) 430-7659
Rallybio@missionnorth.com
Source: Rallybio Corporation